Results 171 to 180 of about 4,520,848 (313)

Targeting type I interferon–mediated activation restores immune function in chronic HIV infection

Journal of Clinical Investigation, 2017
A. Zhen, V. Rezek, Cindy Youn, Brianna B Lam, Nelson Chang, Jonathan Rick, Mayra A. Carrillo, Heather Martin, S. Kasparian, Philip Syed, Nicholas Rice, D. Brooks, S. Kitchen   +12 more
semanticscholar   +1 more source

8 Implication of the HIV-1 pol gene intragenic enhancer in myeloid-specific viral gene expression

Journal of Virus Eradication, 2017
R. Verdikt, L. Colin, C. Vanhulle, B. Van Driessche, A. Kula, V. Monceaux, N. Delacourt, A. David, A. Saez-Cirion, C. Van Lint   +9 more
doaj   +1 more source

Acquired thrombotic thrombocytopenic purpura and HIV infection: a case report and review of the literature. [PDF]

Ann Hematol
Rao S, Liparoti A, Giannotta JA, Artoni A, Muscatello A, Bandera A, Peyvandi F.   +6 more
europepmc   +1 more source

Longitudinal changes in health‐related quality of life after a breast cancer diagnosis in sub‐Saharan Africa: Evidence from the prospective ABC‐DO cohort

International Journal of Cancer, EarlyView.
What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed, Moses Galukande, Allen Naamala, Groesbeck Parham, Leeya Pinder, Angelica Anele, Shadrach Awa Offiah, Annelle Zietsman, Joachim Schüz, Valerie McCormack, Isabel dos‐Santos‐Silva   +10 more
wiley   +1 more source

The persistence and complexity of disordered sleep in well-controlled HIV infection. [PDF]

Sleep
von Schantz M, Scheuermaier K.
europepmc   +1 more source

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

New England Journal of Medicine, 2015
J. Molina, C. Capitant, B. Spire, G. Pialoux, L. Cotte, I. Charreau, C. Tremblay, J. Le Gall, E. Cua, A. Pasquet, F. Raffi, C. Pintado, C. Chidiac, J. Chas, P. Charbonneau, C. Delaugerre, M. Suzan-Monti, B. Loze, J. Fonsart, G. Peytavin, A. Chéret, J. Timsit, G. Girard, N. Lorente, M. Préau, J. Rooney, M. Wainberg, D. Thompson, W. Rozenbaum, V. Doré, L. Marchand, M. Simon, N. Etien, J. Aboulker, L. Meyer, J. Delfraissy   +35 more
semanticscholar   +1 more source

Opportunistic Infections in HIV‐Infected Patients [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 1992
openaire   +3 more sources

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, EarlyView.
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection. [PDF]

Int J Mol Sci
Tarrés-Freixas F, Trinité B, Carrillo J, Blanco J.   +3 more
europepmc   +1 more source

From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Sexually Transmitted Infections, 1999
Douglas T. Fleming, J. Wasserheit
semanticscholar   +1 more source